BFRI: Biofrontera Inc Company Profile & Statistics

About

Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera Inc. is based in WOBURN, MA.

Info & Links

CEO

Hermann L¿bbert

Headquarters

120 PRESIDENTIAL WAY, SUITE 330
WOBURN, MA 01801, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Biofrontera Inc Statistics

Valuation Measures

Market Capitalization²

7.83M

Enterprise Value

4.95M

Enterprise Value/EBITDA(ttm)

-0.27

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.23

Price to Book(mrq)

1.25

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

46.95%

Operating Margin(ttm)

-63.27%

Profit Margin(ttm)

-41.20%

Return on Equity(ttm)

-565.73%

Return on Invested Capital(ttm)

534.08%

Return on Assets(ttm)

-96.64%

Income Statement

Revenue(ttm)

35.36M

Revenue Per Share(ttm)

4.56

Gross Profit(ttm)

16.65M

EBITDA(ttm)³

-18.14M

Net Income Available to Common(ttm)

-12.84M

Diluted EPS(ttm)

-2.26

Share Statistics

Beta (5Y Monthly)

0.38

52-Week Change

-71.94%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

7.75M

Dividend Yield

0.00%

Float⁴

7.73M

% Held by Insiders

0.21%

% Held by Institutions

10.08%

Balance Sheet

Total Cash(mrq)

2.88M

Total Cash Per Share(mrq)

0.37

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.53%

Quick Ratio(mrq)

0.94%

Book Value Per Share(mrq)

0.85

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.60

Free Cash Flow(ytd)

-9.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BFRI

Biofrontera Inc

Biofrontera Inc Profile